Other Species / Isoforms
  RFFL (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
-
gap
0 1
RFFL (human) gap -
RFFL iso2 (human) gap -
RFFL (mouse) gap -
RFFL iso3 (mouse) RSFFGQPtVCCGsVL T20-p
RFFL (rat) gap -
-
gap
0 1
RFFL (human) gap -
RFFL iso2 (human) gap -
RFFL (mouse) gap -
RFFL iso3 (mouse) QPtVCCGsVLRQAKA S25-p
RFFL (rat) gap -
Y29-p
QGARMQAysNPGySs
0 30
RFFL (human) QGARMQAysNPGySs Y29-p
RFFL iso2 (human) QGARMQAYSNPGYSS Y29
RFFL (mouse) QGARTQAySNPGySS Y43-p
RFFL iso3 (mouse) QGARTQAYSNPGYSS Y64
RFFL (rat) QGARTQAYSNPGYSS Y29
S30-p
GARMQAysNPGySsF
0 11
RFFL (human) GARMQAysNPGySsF S30-p
RFFL iso2 (human) GARMQAYSNPGYSSF S30
RFFL (mouse) GARTQAySNPGySSF S44
RFFL iso3 (mouse) GARTQAYSNPGYSSF S65
RFFL (rat) GARTQAYSNPGYSSF S30
Y34-p
QAysNPGySsFPsPT
Upstream
0 134
Treatment
  • IL-15
RFFL (human) QAysNPGySsFPsPT Y34-p
RFFL iso2 (human) QAYSNPGYSSFPSPT Y34
RFFL (mouse) QAySNPGySSFPSPT Y48-p
RFFL iso3 (mouse) QAYSNPGYSSFPSPT Y69
RFFL (rat) QAYSNPGYSSFPSPT Y34
S36-p
ysNPGySsFPsPTGL
0 1
RFFL (human) ysNPGySsFPsPTGL S36-p
RFFL iso2 (human) YSNPGYSSFPSPTGL S36
RFFL (mouse) ySNPGySSFPSPTGS S50
RFFL iso3 (mouse) YSNPGYSSFPSPTGS S71
RFFL (rat) YSNPGYSSFPSPTGS S36
S39-p
PGySsFPsPTGLEPS
Upstream
0 2
Treatment
  • ischemia
RFFL (human) PGySsFPsPTGLEPS S39-p
RFFL iso2 (human) PGYSSFPSPTGLEPS S39
RFFL (mouse) PGySSFPSPTGSEPS S53
RFFL iso3 (mouse) PGYSSFPSPTGSEPS S74
RFFL (rat) PGYSSFPSPTGSEPS S39
T57-p
CGAHFANtARKQTCL
0 6
RFFL (human) CGAHFANtARKQTCL T57-p
RFFL iso2 (human) CGAHFANTARKQTCL T57
RFFL (mouse) CGVHFASTTRKQTCL T71
RFFL iso3 (mouse) CGVHFASTTRKQTCL T92
RFFL (rat) CGVHFASTTRKQTCL T57
K105-ac
REELMKMkVKDLRDY
0 4
RFFL (human) REELMKMkVKDLRDY K105-ac
RFFL iso2 (human) REELMKMKVKDLRDY K105
RFFL (mouse) REELMKMKVKDLRDY K119
RFFL iso3 (mouse) REELMKMKVKDLRDY K140
RFFL (rat) REELMKMKVKDLRDY K105
K126-ub
STEMCREkEELVLLV
0 2
RFFL (human) STEMCREkEELVLLV K126-ub
RFFL iso2 (human) STEMCREKEELVLLV K126
RFFL (mouse) STEMCREKEELVFLV K140
RFFL iso3 (mouse) STEMCREKEELVFLV K161
RFFL (rat) STEMCREKEELVFLV K126
S149-p
QEDRTRAstLsPDFP
0 7
RFFL (human) QEDRTRAstLsPDFP S149-p
RFFL iso2 (human) QEDRTRASTLSPDFP S149
RFFL (mouse) EADRTRVPHLPQAFP P163
RFFL iso3 (mouse) EADRTRVPHLPQAFP P184
RFFL (rat) EADRTRAPTLPQAFP P149
T150-p
EDRTRAstLsPDFPE
Upstream
0 30
Treatment
  • imatinib
  • wortmannin
RFFL (human) EDRTRAstLsPDFPE T150-p
RFFL iso2 (human) EDRTRASTLSPDFPE T150
RFFL (mouse) ADRTRVPHLPQAFPE H164
RFFL iso3 (mouse) ADRTRVPHLPQAFPE H185
RFFL (rat) ADRTRAPTLPQAFPE T150
S152-p
RTRAstLsPDFPEQQ
0 1
RFFL (human) RTRAstLsPDFPEQQ S152-p
RFFL iso2 (human) RTRASTLSPDFPEQQ S152
RFFL (mouse) RTRVPHLPQAFPEQQ P166
RFFL iso3 (mouse) RTRVPHLPQAFPEQQ P187
RFFL (rat) RTRAPTLPQAFPEQQ P152
Y211-p
QDQEEPVyLESVARV
0 13
RFFL (human) QDQEEPVyLESVARV Y211-p
RFFL iso2 (human) QDQEEPVYLESVARV Y211
RFFL (mouse) QDHEEPIFPESTARV F225
RFFL iso3 (mouse) QDHEEPIFPESTARV F246
RFFL (rat) QDHEEPIFLESTARV F210
T224-p
RVPAEDEtQsIDsED
0 5
RFFL (human) RVPAEDEtQsIDsED T224-p
RFFL iso2 (human) RVPAEDETQSIDSED T224
RFFL (mouse) RVPTEDETQsVDsED T238
RFFL iso3 (mouse) RVPTEDETQSVDSED T259
RFFL (rat) RVPPEDETQsVDsED T223
S226-p
PAEDEtQsIDsEDsF
0 25
RFFL (human) PAEDEtQsIDsEDsF S226-p
RFFL iso2 (human) PAEDETQSIDSEDSF S226
RFFL (mouse) PTEDETQsVDsEDsF S240-p
RFFL iso3 (mouse) PTEDETQSVDSEDSF S261
RFFL (rat) PPEDETQsVDsEDSF S225-p
S229-p
DEtQsIDsEDsFVPG
0 31
RFFL (human) DEtQsIDsEDsFVPG S229-p
RFFL iso2 (human) DETQSIDSEDSFVPG S229
RFFL (mouse) DETQsVDsEDsFVPG S243-p
RFFL iso3 (mouse) DETQSVDSEDSFVPG S264
RFFL (rat) DETQsVDsEDSFVPG S228-p
S232-p
QsIDsEDsFVPGRRA
0 7
RFFL (human) QsIDsEDsFVPGRRA S232-p
RFFL iso2 (human) QSIDSEDSFVPGRRA S232
RFFL (mouse) QsVDsEDsFVPGRRA S246-p
RFFL iso3 (mouse) QSVDSEDSFVPGRRA S267
RFFL (rat) QsVDsEDSFVPGRRA S231
S240-p
FVPGRRAsLsDLtDL
Upstream
0 58
Treatment
  • ischemia
  • metastatic potential
RFFL (human) FVPGRRAsLsDLtDL S240-p
RFFL iso2 (human) FVPGRRASLSDLTDL S240
RFFL (mouse) FVPGRRAsLsDLtHL S254-p
RFFL iso3 (mouse) FVPGRRASLSDLTHL S275
RFFL (rat) FVPGRRAsLSDLTHL S239-p
S242-p
PGRRAsLsDLtDLED
Upstream
0 13
Treatment
  • metastatic potential
RFFL (human) PGRRAsLsDLtDLED S242-p
RFFL iso2 (human) PGRRASLSDLTDLED S242
RFFL (mouse) PGRRAsLsDLtHLED S256-p
RFFL iso3 (mouse) PGRRASLSDLTHLED S277
RFFL (rat) PGRRAsLSDLTHLED S241
T245-p
RAsLsDLtDLEDIEG
0 8
RFFL (human) RAsLsDLtDLEDIEG T245-p
RFFL iso2 (human) RASLSDLTDLEDIEG T245
RFFL (mouse) RAsLsDLtHLEDIEG T259-p
RFFL iso3 (mouse) RASLSDLTHLEDIEG T280
RFFL (rat) RAsLSDLTHLEDIEG T244
K270-ub
ARNFVNYkGCCEKWE
0 1
RFFL (human) ARNFVNYkGCCEKWE K270-ub
RFFL iso2 (human) ARNFVNYKGCCEKWE K270
RFFL (mouse) ARNFVNYKGCCEKWE K284
RFFL iso3 (mouse) ARNFVNYKGCCEKWE K305
RFFL (rat) ARNFVNYKGCCEKWE K269
Y353
ECPICRQYVIRAVHV
0 1
RFFL (human) ECPICRQYVIRAVHV Y353
RFFL iso2 (human) ECPICRQYVIRAVHV Y345
RFFL (mouse) ECPICRQyVIRAVHV Y367-p
RFFL iso3 (mouse) ECPICRQYVIRAVHV Y388
RFFL (rat) ECPICRQYVIRAVHV Y352